No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
359,양도완료,개별종목,2024-05-21,롯데손해보험,재평가,NH-AMUNDI아부다비인프라사모특별자산투자신탁3호,KBP2021030048,B02,0,-,분기 ,2024-06-30,평가철회,평가철회,-,대체평가3사업본부, - ,대체평가3사업본부,정창수,정창수,평가철회,평가철회,운용지원팀조선화책임,sunhwa.jo@lotteins.co.kr,410000343,-,0
502,-,개별종목,매분기,SK,재평가,SK,1101110769583 ,D06,6,-,분기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김진희매니저,02-6400-5153,jinhuikim@sk.com,회계반영,2
503,-,개별종목,매분기,SK,재평가,SK,1101110769583 ,D06,1,-,분기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김진희매니저,02-6400-5153,jinhuikim@sk.com,회계반영,2
504,-,개별종목,매분기,SK,재평가,SK,1101110769583 ,D06,2,-,분기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김진희매니저,02-6400-5153,jinhuikim@sk.com,회계반영,2
1182,MRC/백데이터자료제공 :  2024-07-11,개별종목,2024-05-28,삼성증권(PI본부),재평가,현대인베스트해밀턴레인세컨더리PE전문투자형투자신탁2호,KBP2021030030,B02,99,-,분기 ,2024-06-30,2024-07-03,2024-07-09,2024-07-11,대체평가3사업본부, - ,대체평가3사업본부,이소연,이소연,202406,[T]기타보험기관[1본부],"전주원, 서우석","02-2020-8225, 02-2020-7825",juwon09.chun@samsung.com; ws777.seo@samsung.com ,-,0
2598,-,개별종목,2024-05-30,"신한벤처투자(구,네오플럭스)",재평가,"아이엠에스원(구,비마이카)",1101115120946 ,A01,0,-,반기 ,2024-06-30,일정연기,일정연기,-,서경덕, 1.0 ,조현우,강승현,강승현,202406,[Y]금융기관,안예진사원,02-560-9726,yjan@shinhanvc.com,LP제출,2
2599,-,개별종목,2024-05-30,"신한벤처투자(구,네오플럭스)",재평가,"아이엠에스원(구,비마이카)",1101115120946 ,A07,1,-,반기 ,2024-06-30,일정연기,일정연기,-,서경덕, - ,조현우,강승현,강승현,202406,[Y]금융기관,안예진사원,02-560-9726,yjan@shinhanvc.com,LP제출,2
2600,-,개별종목,2024-05-30,"신한벤처투자(구,네오플럭스)",재평가,"아이엠에스원(구,비마이카)",1101115120946 ,A07,2,-,반기 ,2024-06-30,일정연기,일정연기,-,서경덕, - ,조현우,강승현,강승현,202406,[Y]금융기관,안예진사원,02-560-9726,yjan@shinhanvc.com,LP제출,2
2601,-,개별종목,2024-05-30,"신한벤처투자(구,네오플럭스)",재평가,"아이엠에스원(구,비마이카)",1101115120946 ,A07,3,-,반기 ,2024-06-30,일정연기,일정연기,-,서경덕, - ,조현우,강승현,강승현,202406,[Y]금융기관,안예진사원,02-560-9726,yjan@shinhanvc.com,LP제출,2
4934,-,개별종목,2024-06-03,쿠쿠홀딩스,재평가,유모멘트,1101117236634 ,A00,0,-,분기,2024-06-30,평가철회,평가철회,-,신원준, - ,고명주,정재형,정재형,평가철회,평가철회,김동민담당자,055-380-0737,dmkim@cuckoo.co.kr,회계반영,0
4935,-,개별종목,2024-06-03,쿠쿠홀딩스,재평가,유모멘트,1101117236634 ,D02,1,-,분기,2024-06-30,평가철회,평가철회,-,신원준, - ,고명주,정재형,정재형,평가철회,평가철회,김동민담당자,055-380-0737,dmkim@cuckoo.co.kr,회계반영,0
5802,-,개별종목,2024-06-07,에스케이증권,재평가,하이그라운드,1101115425312 ,A05,1,-,반기 ,2024-06-30,2024-07-03,2024-07-12,-,서경덕, 1.0 ,서수빈,변혜진,변혜진,202406,[Y]금융기관,정지수주임,02-3773-9595,matcha@sks.co.kr,-,0
5848,-,개별종목,2024-06-05,네이버,재평가,"웨딩북(구,하우투메리)",1101115391448 ,A00,0,-,반기,2024-06-30,평가철회,평가철회,-,김수현, 1.0 ,김수현,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
5849,-,개별종목,2024-06-05,네이버,재평가,"웨딩북(구,하우투메리)",1101115391448 ,A07,0,-,반기,2024-06-30,평가철회,평가철회,-,김수현, - ,김수현,원정우,원정우,평가철회,평가철회,김병각,"031-784-4211, 010-3080-4775",byunggak.kim@navercorp.com ,-,0
6248,보통주전환,기초자산,무림캐피탈펀드(기초자산),에스브이바이오제1호사모투자,재평가,큐리언트,1101113926875 ,A01,0,-,반기 ,2024-06-30,평가철회,평가철회,-,상장, - ,상장,-,-,평가철회,평가철회,0,0,0,-,0
6580,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,재평가,엔켐,1512110026289 ,D02,0,-,분기,2024-06-30,2024-07-08,보고서제공X,-,상장, - ,상장,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
6581,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,재평가,나노신소재,1601110094162 ,D03,0,-,분기,2024-06-30,2024-07-08,보고서제공X,-,상장, - ,상장,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
6582,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,재평가,"Biocentiq, Inc.",KBP2023120125,A07,0,-,분기,2024-06-30,2024-07-08,보고서제공X,-,채동우, - ,채동우,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
6583,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,재평가,"채비(구,대영채비)",1701110604795 ,A07,2,-,분기,2024-06-30,2024-07-08,보고서제공X,-,김수현, - ,김수현,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
6617,-,개별종목,2024-07-01,아이엠엠인베스트먼트,재평가,지에스아이티엠,1101113451731 ,A01,0,-,반기,2024-06-30,2024-07-11,2024-07-11,-,오수현, 1.0 ,오수현,강성은,강성은,202406,[Y]금융기관,노지영매니저,02-2112-1814,gyroh@imm.co.kr,LP제출목적,2
6618,-,개별종목,2024-07-01,아이엠엠인베스트먼트,재평가,지에스아이티엠,1101113451731 ,A07,0,-,반기,2024-06-30,2024-07-11,2024-07-11,-,오수현, - ,오수현,강성은,강성은,202406,[Y]금융기관,노지영매니저,02-2112-1814,gyroh@imm.co.kr,LP제출목적,2
6620,-,개별종목,2024-07-01,아이엠엠인베스트먼트,재평가,케렌시아원,1101140232477 ,A01,0,-,반기,2024-06-30,2024-07-11,2024-07-11,-,강승현, 1.0 ,강승현,강성은,강성은,202406,[Y]금융기관,노지영매니저,02-2112-1814,gyroh@imm.co.kr,LP제출목적,2
6645,-,개별종목,2024-07-03,아이오케이컴퍼니(상장),재평가,"에스비더블유생명과학(구,나노스)",1358110109900 ,D02,6,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,허준호대리 ,010-2287-1378 ,90hjhy87@iok.co.kr ,-,0
6646,-,개별종목,2024-07-03,롯데손해보험,재평가,KCGI-ETIHAD-B777F일반사모특별자산투자신탁,KBP2016060231,B02,0,-,분기 ,2024-06-30,2024-07-03,2024-07-16,-,대체평가3사업본부, - ,대체평가3사업본부,정창수,정창수,202406,[T]기타보험기관[1본부],운용지원팀조선화책임,sunhwa.jo@lotteins.co.kr,410000208,-,0
6647,-,기초자산,디비저축은행펀드(기초자산),디에스무림신기술투자조합제1호,재평가,트리엔,1748110032229 ,A07,0,-,분기,2024-06-30,2024-07-05,보고서제공X,-,변혜진, - ,변혜진,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6648,-,기초자산,"한화생명보험(수익증권형대출), 교보생명(투자자산관리팀)수익증권(기초자산)",한화광주순환도로사모특별자산투자신탁1호,재평가,광주제2순환도로,2001110191224 ,B05,0,-,분기 ,2024-06-30,2024-07-05,보고서제공X,-,김범준, 0.4 ,김범준,-,-,202406,[U]기타보험기관(기초자산),0,0,0,-,0
6649,-,기초자산,"삼성증권(PM팀)(구,전략투자팀),미래에셋생명(지분증권)펀드(기초자산)",IMMGrowth벤처펀드제1호,신규,큐픽스,1101115812733 ,A07,0,-,분기,2024-06-30,2024-07-03,보고서제공X,-,신원준, - ,신원준,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6650,-,기초자산,디비저축은행펀드(기초자산),NH-수성제1호메자닌신기술투자조합,신규,코어라인소프트,1101114962092 ,D02,0,-,분기,2024-06-30,2024-07-05,보고서제공X,-,상장, - ,상장,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6651,-,개별종목,2024-07-03,오스틴제약,재평가,오스틴제약,1348110014837 ,A01,0,-,미정,2024-06-30,2024-07-19,2024-07-26,-,윤광일, 1.0 ,허정욱,윤광일,윤광일,202406,[X]일반기업,손한나주임,070-4443-0664,shn@bs-group.kr,회계반영,0
6652,-,개별종목,2024-07-03,오스틴제약,재평가,오스틴제약,1348110014837 ,A05,0,-,미정,2024-06-30,2024-07-19,2024-07-26,-,윤광일, - ,허정욱,윤광일,윤광일,202406,[X]일반기업,손한나주임,070-4443-0664,shn@bs-group.kr,회계반영,0
6653,-,개별종목,2024-07-03,오스틴제약,재평가,오스틴제약,1348110014837 ,D06,0,-,미정,2024-06-30,2024-07-19,2024-07-26,-,윤광일, - ,허정욱,윤광일,윤광일,202406,[X]일반기업,손한나주임,070-4443-0664,shn@bs-group.kr,회계반영,0
6654,-,개별종목,2024-07-03,솔고바이오메디칼,재평가,솔고바이오메디칼,1347110014590 ,D02,13,-,미정,2024-06-30,2024-07-10,2024-07-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김대진차장,010-2574-4758,kdj0829@solco.co.kr,회계반영,0
6655,-,개별종목,2024-07-03,솔고바이오메디칼,재평가,솔고바이오메디칼,1347110014590 ,D02,133,-,미정,2024-06-30,2024-07-10,2024-07-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김대진차장,010-2574-4758,kdj0829@solco.co.kr,회계반영,0
6656,-,개별종목,2024-07-03,솔고바이오메디칼,재평가,솔고바이오메디칼,1347110014590 ,D02,14,-,미정,2024-06-30,2024-07-10,2024-07-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김대진차장,010-2574-4758,kdj0829@solco.co.kr,회계반영,0
6657,-,개별종목,2024-07-03,솔고바이오메디칼,재평가,솔고바이오메디칼,1347110014590 ,D02,144,-,미정,2024-06-30,2024-07-10,2024-07-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김대진차장,010-2574-4758,kdj0829@solco.co.kr,회계반영,0
6658,-,기초자산,시냅틱인베스트먼트펀드(기초자산),시냅틱미래성장제1호사모투자,신규,쎄닉,1101117931896 ,D02,0,-,분기,2024-06-30,2024-07-08,보고서제공X,-,심태진, - ,심태진,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,2
